Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations (2017)
- Authors:
- USP affiliated authors: FRANÇOSO, KATIA SANCHES - FCF ; SOARES, IRENE DA SILVA - FCF
- Unidade: FCF
- Subjects: MALÁRIA; PLASMODIUM; VACINAS; ADJUVANTES IMUNOLÓGICOS
- Language: Inglês
- Imprenta:
- Source:
- Título: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 53, suppl. 1, p. 51 res. FCF097, 2017
- Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo
-
ABNT
MARQUES, Rodolfo Ferreira et al. Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 19 nov. 2024. , 2017 -
APA
Marques, R. F., Gimenez, A. M., Françoso, K. S., & Soares, I. da S. (2017). Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. -
NLM
Marques RF, Gimenez AM, Françoso KS, Soares I da S. Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 51 res. FCF097.[citado 2024 nov. 19 ] -
Vancouver
Marques RF, Gimenez AM, Françoso KS, Soares I da S. Immunogenicity of a malaria vaccine candidate based on allelic forms of the plasmodium vivax circumsporozoite antigen administered in mice using different adjuvant formulations. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 51 res. FCF097.[citado 2024 nov. 19 ] - Plasmodium vivax malaria vaccine: immunization with a novel chimeric recombinant protein generates high IgG antibody titers and IFN-γ-secreting cells in mice
- Plasmodium vivax malaria vaccine: immunization with a novel chimeric recombinant protein generates high IgG antibody titers and IFN-y-secreting cells in mice
- Geração de proteínas recombinantes quiméricas para uso em vacinação experimental contra o Plasmodium vivax
- 'CD8 POT. 8' T-cell-mediated immunity against malaria: a novel heterologous prime-boost strategy
- Imunogenicity of a malaria vaccine candidate based on allelic forms of the Plasmodium vivax circumsporozoite protein administered in mice using different adjuvant formulations
- Immunogenicity of a multi-antigen formulation based on plasmodium vivax malaria vaccine candidates
- Invasion-inhibitory antibodies elicited by immunization with Plasmodium vivax apical membrane antigen-1 expressed in Pichia pastoris yeast
- Prime-boost vaccination with recombinant protein and adenovirus-vector expressing Plasmodium vivax circumsporozoite protein (CSP) partially protects mice against Pb/Pv sporozoite challenge
- Comparação da imunogenicidade de duas proteínas recombinantes baseadas na proteína circumsporozoíta (CS) de Plasmodium vivax
- Naturally acquired immune response against a chimeric protein representing two highly antigenic proteins of plasmodium vitax
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
